Pfizer and Moderna used the mRNA technology to produce the COVID-19 vaccine. Vaccines using mRNA have potential uses far beyond immunization—to treat cancer, for instance, or addiction.
The company announced a program to develop vaccines for the seasonal flu, the Nipah virus (a virus that can cause various conditions, including encephalitis), and HIV.
While the research to develop an HIV vaccine has been ongoing so far no candidate has been successful. In the past few years, Moderna had been working on possible vaccine candidates.
A successful vaccine would be a groundbreaking development in the quest to eliminate HIV, a virus that kills nearly 700,000 people a year worldwide.
Although HIV is a much more complex virus than the coronavirus, and it will likely still take years before a vaccine, even an mRNA-based one, is available.